Wilmington, DE, United States of America

Dan Widzowski

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 11.7

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2012-2014

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Dan Widzowski

Introduction

Dan Widzowski is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating various mental health disorders. With a total of 3 patents, Widzowski's work has the potential to impact many lives.

Latest Patents

Widzowski's latest patents include innovative compounds such as dibenzothiazepine derivatives and their uses. These compounds are designed to treat bipolar disorder, anxiety disorders, mood disorders, schizophrenia, and other psychotic disorders. His work also encompasses crystalline forms of 11-piperazin-1-yldibenzo[b,f][1,4]thiazepine, along with compositions, preparations, formulations, prodrugs, and pharmaceutical applications related to these compounds.

Career Highlights

Throughout his career, Widzowski has worked with prominent organizations, including AstraZeneca and Yale University. His experience in these institutions has allowed him to collaborate with leading experts in the field, further enhancing his contributions to pharmaceutical innovation.

Collaborations

Some of Widzowski's notable coworkers include James Hulsizer and Phil Edwards. Their collaborative efforts have likely played a role in advancing the research and development of the compounds he has patented.

Conclusion

Dan Widzowski's innovative work in pharmaceuticals demonstrates his commitment to improving mental health treatment through his patented inventions. His contributions are a testament to the importance of research and collaboration in the field of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…